Laura Nevado-Del Puerto
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Early posturographic changes as predictors of functional recovery after stroke: a proof of concept.
Journal: European journal of physical and rehabilitation medicine
Published: July 03, 2026
Immune Modulation Through KIR-HLA Interactions Influences Cetuximab Efficacy in Colorectal Cancer.
Journal: International journal of molecular sciences
Published: June 23, 2025
POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma.
Journal: Frontiers in oncology
Published: May 15, 2024
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Journal: British journal of cancer
Published: April 04, 2024
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Journal: British journal of cancer
Published: October 16, 2023
Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 23, 2021
Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance.
Journal: Cancers
Published: June 25, 2021
Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.
Journal: Journal for immunotherapy of cancer
Published: March 06, 2021
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas.
Journal: Neuroendocrinology
Published: November 09, 2019
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.
Journal: Scientific reports
Published: May 18, 2019
Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction.
Journal: Molecular oncology
Published: January 28, 2019
Last Updated: 09/26/2026